Related Experiment Videos
Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease
1Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Abstract:
Cholinergic transmission at muscarinic acetylcholine receptors (mAChR) has been implicated in higher brain functions such as learning and memory, and loss of synapses may contribute to the symptoms of Alzheimer disease. A heterogeneous family of five genetically distinct mAChR subtypes differentially modulate a variety of intracellular signaling systems as well as the processing of key molecules involved in the pathology of the disease. Although many muscarinic effects have been identified in memory circuits, including a diversity of pre- and post-synaptic actions in hippocampus, the identities of the molecular subtypes responsible for any given function remain elusive. All five mAChR genes are expressed in hippocampus, and subtype-specific antibodies have enabled identification, quantification, and localization of the encoded proteins. The m1, m2, and m4 mAChR proteins are most abundant in forebrain regions and they have distinct cellular and subcellular localizations suggestive of various pre- and postsynaptic functions in cholinergic circuits. The subtypes are also differentially altered in postmortem brain samples from Alzheimer disease cases. Further understanding of the molecular pharmacology of failing synapses in Alzheimer disease, together with the development of new subtype-selective drugs, may provide more specific and effective treatments for the disease.
Insights
Cholinergic signaling via muscarinic acetylcholine receptors (mAChR) is vital for learning and memory. Alzheimer's disease may involve synapse loss, with specific mAChR subtypes showing altered expression in affected brain regions.
Area of Science:
- Neuroscience
- Molecular Pharmacology
- Neurodegenerative Diseases
Background:
- Cholinergic transmission, mediated by muscarinic acetylcholine receptors (mAChR), plays a crucial role in cognitive functions like learning and memory.
- Synaptic loss is a key feature in Alzheimer disease (AD) pathology.
- The five mAChR subtypes differentially regulate intracellular signaling and molecular processing relevant to AD.
Purpose of the Study:
- To investigate the roles of specific mAChR subtypes in hippocampal function and their alterations in Alzheimer disease.
- To identify the molecular subtypes responsible for specific cognitive functions.
- To explore the potential for subtype-selective therapeutics for AD.
Main Methods:
- Utilized subtype-specific antibodies for identification, quantification, and localization of mAChR proteins in the hippocampus.
- Analyzed mAChR protein expression and localization in both healthy and postmortem Alzheimer disease brain samples.
- Examined the differential expression and cellular distribution of m1, m2, and m4 mAChR subtypes.
Main Results:
- All five mAChR subtypes are expressed in the hippocampus.
- The m1, m2, and m4 mAChR proteins are highly abundant in forebrain regions with distinct cellular and subcellular localizations.
- Significant alterations in mAChR subtype expression were observed in postmortem brain samples from Alzheimer disease patients.
Conclusions:
- Specific mAChR subtypes (m1, m2, m4) have distinct roles in cholinergic circuits within the hippocampus.
- Dysregulation of these mAChR subtypes is implicated in the pathophysiology of Alzheimer disease.
- Targeting specific mAChR subtypes offers a promising strategy for developing novel, effective Alzheimer disease treatments.